Head-to-head · WeighScore
Fitstry vs NuvaHealth
The verdict
NuvaHealth takes it — 74/100 to 61.2/100.
NuvaHealth grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. NuvaHealth (nuvahealth.org) is a LegitScript-certified compounded GLP-1 telehealth platform offering compounded semaglutide starting at $159 first-month and compounded tirzepatide starting at $259 first-month.
We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.
Factor by factor
The same six graded dimensions, side by side. See the methodology.
The numbers
| Metric | Fitstry | NuvaHealth |
|---|---|---|
| WeighScore | 61.2/100 | 74/100 |
| Grade | C | C |
| Scorecard rank | #300 | #68 |
| Semaglutide | $179/mo (annual plan, plus a separate fee, compounded) | $139/mo (first-month rate, compounded) |
| Tirzepatide | $269/mo (annual plan, compounded) | $229/mo (first-month rate, compounded) |
| Coverage | Coverage not published | Coverage not published |
| Brand-name access | Compounded only | Yes |
| Oral / sublingual | Yes | Yes |
Graded #300 · C
Strengths
- Transparent pricing before you commit — compounded semaglutide from $179/mo, tirzepatide from $269/mo, oral GLP-1 from $209/mo (annual plan)
- Free screening with a one-time $99 program fee that is fully refunded if a clinician can't prescribe ('Approved, or Your $99 Back')
- Monthly price bundles a lab panel (CMP, A1c, lipids, TSH), unlimited clinician access, bi-weekly care coaching and a 24/7 Care Line
- Runs under Weightstry, LLC, a LegitScript-certified practice with an independently verifiable seal, a named support email and phone
- Full compounded lineup — weekly injection, daily oral tablet and microdosing options
Where it loses points
- Month-to-month pricing is notably higher than the annual plan ($249 vs $179 semaglutide, $339 vs $269 tirzepatide)
- Compounded semaglutide and tirzepatide only — no brand-name (Wegovy/Zepbound) options
- Framed for women 40+, and serves 49 states rather than all 50 (the excluded state isn't disclosed publicly)
- Works with state-licensed compounding pharmacies but doesn't name a specific pharmacy partner on the Fitstry page
- Compounded GLP-1s are not FDA-reviewed or approved — a different evidence and regulatory tier than brand-name
Graded #68 · C
Strengths
- LegitScript Certified seal displayed on the marketing site (the standard third-party telehealth/pharmacy accreditation)
- Free and fast delivery + 24/7 patient support disclosed on the home page
- Newark, DE address suggests a US-incorporated entity (vs offshore)
- $139 first-month price for compounded semaglutide injection is among the cheapest in the US compounded telehealth market
- $229 first-month price for compounded tirzepatide injection sits in the lower-median range
Where it loses points
- Standard ongoing monthly price NOT publicly disclosed (gated behind checkout) — patients should ask for the maintenance-dose price before committing
- Specific legal entity name + state of incorporation NOT publicly disclosed on the home page — material YMYL transparency gap
- Pharmacy partners NOT publicly named — material YMYL transparency gap
- Per-state availability NOT enumerated; verify your state ships before purchase
- Lab work + coaching support NOT publicly disclosed
Also worth a look
Neither is our top-graded pick — CoreAge Rx leads the scorecard
Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.
Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.